AI-assisted, human-published
05/21/2026 /Funding Events
Cagent Vascular Reaches Key Milestones and Secures $41 Million in Series D Funding
Cagent Vascular achieves milestones with Serranator® SONIC IVL System and closes $41 million Series D financing round to support global REMODEL II pivotal trial and commercial launch of the SONIC IVL System.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com